1,318
Views
3
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China

ORCID Icon, , , , , & show all
Article: 2126667 | Received 30 May 2022, Accepted 16 Sep 2022, Published online: 27 Sep 2022

References

  • CDC. Safety of the COVID-19 vaccines. 2022 May 16. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html.
  • Holder J. Tracking Coronavirus vaccinations around the World. The New York Times; 2022 May 18. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html.
  • Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC. Immunity to SARS-CoV-2 up to 15 months after infection. ISci. 2022 Jan;7(2):1.
  • Lou F, Li M, Pang Z, Jiang L, Guan L, Tian L, Hu J, Fan J, Fan H. Understanding the secret of SARS-CoV-2 variants of concern/interest and immune escape. Front Immunol. 2021;12:4326.
  • Burckhardt RM, Dennehy JJ, Poon LL, Saif LJ, Enquist LW. Are COVID-19 vaccine boosters needed? the science behind boosters. J Virol. 2021 Nov 24;96(3): e01973-21.
  • CDC. COVID-19 vaccine booster shots. 2022 May 13. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html.
  • Zhang W. COVID-19 vaccination rate in China 2021-2022, by status. Statista; 2022 May 9. https://www.statista.com/statistics/1279024/china-coronavirus-covid-19-vaccination-rate/.
  • CCTV. National health commission: over 700 million people complete booster immunization. 2022 Apr 29. http://news.cctv.com/2022/04/29/ARTIhw56yOrYtSUyG93mjXsX220429.shtml.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP, Marques ETA. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961.
  • Wu J, Ma M, Miao Y, Ye B, Li Q, Tarimo CS, Wang M, Gu J, Wei W, Zhao L. COVID-19 vaccination acceptance among Chinese population and its implications for the pandemic: a national cross-sectional study. Front Pub Health. 2022;10:796467. doi:10.3389/fpubh.2022.796467
  • Huang Y, Su X, Xiao W, Wang H, Si M, Wang W, Gu X, Ma L, Li L, Zhang S. COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey. BMC Infect Dis. 2022 Dec;22(1):1–11. doi:10.1186/s12879-022-07111-0.
  • Shakeel CS, Mujeeb AA, Mirza MS, Chaudhry B, Khan SJ. Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines. 2022 Jan;10(1):110. doi:10.3390/vaccines10010110.
  • Snehota M, Vlckova J, Cizkova K, Vachutka J, Kolarova H, Klaskova E, Kollarova H. Acceptance of a vaccine against COVID-19-a systematic review of surveys conducted worldwide. Bratisl Lek Listy. 2021 Jan 1;122(8):538–47.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021 Feb 16;9(2):160. doi:10.3390/vaccines9020160.
  • Wong LP, Alias H, Danaee M, Ahmed J, Lachyan A, Cai CZ, Lin Y, Hu Z, Tan SY, Lu Y. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. 2021 Dec;10(1):1–4. doi:10.1186/s40249-021-00900-w.
  • Wu F, Yuan Y, Deng Z, Yin D, Shen Q, Zeng J, Xie Y, Xu M, Yang M, Jiang S. Acceptance of COVID‐19 booster vaccination based on the Protection Motivation Theory (PMT): a cross‐sectional study in China. J Med Virol. 2022 May 4;94(9):4115–214. doi:10.1002/jmv.27825.
  • Wang X, Liu L, Pei M, Li X, Li N. Willingness of the general public to receive a COVID-19 vaccine booster—china, April–May 2021. China CDC Weekly. 2022 Jan 28;4(4):66–70.
  • Tung TH, Lin XQ, Chen Y, Zhang MX, Zhu JS. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2022 Feb 1;21(2):261–67.
  • Qin C, Wang R, Tao L, Liu M, Liu J. Acceptance of a third dose of COVID-19 vaccine and associated factors in China based on health belief model: a national cross-sectional study. Vaccines. 2022 Jan;10(1):89. doi:10.3390/vaccines10010089.
  • Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, Zhang H, Feng H, Guo J, Fang H. Public perceptions and acceptance of COVID-19 booster vaccination in China: a cross-sectional study. Vaccines. 2021 Dec;9(12):1461. doi:10.3390/vaccines9121461.
  • Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022 Jun 23;22(9):1293–302.
  • Roy DN, Biswas M, Islam E, Azam MS, Delcea C. Potential factors influencing COVID-19 vaccine acceptance and hesitancy: a systematic review. PloS One. 2022 Mar 23;17(3):e0265496.
  • Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. 4th ed. San Fracisco: John Wiley & Sons; 2008.
  • Wong LP, Wu Q, Hao Y, Chen X, Chen Z, Alias H, Shen M, Hu J, Duan S, Zhang J. The role of institutional trust in preventive practices and treatment-seeking intention during the coronavirus disease 2019 outbreak among residents in Hubei, China. Int Health. 2022 Mar;14(2):161–69. doi:10.1093/inthealth/ihab023.
  • De Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020 Sep 26;396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • Champion V, Skinner CS. The health belief model. In: Glanz K, Rimer B, Viswanath K, editors. Health behavior and health education. Vol. 4. San Francisco (CA): Jossey-Bass; 2008. p. 45–65.
  • Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015 Feb 25;7. doi:10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4
  • Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken (NJ): John Wiley; 2013.
  • Al-Qerem W, Al Bawab AQ, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines. 2022 Mar 9;10(3):410. doi:10.3390/vaccines10030410.
  • Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. 2021 Dec;9(12):1424. doi:10.3390/vaccines9121424.
  • Sønderskov KM, Vistisen HT, Dinesen PT, Østergaard SD. COVID-19 booster vaccine willingness. Dan Med J. 2022 Dec 7;69(1):A10210765.
  • Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, Hasan MT, Sessou P, Ditekemena JD, Amodan BO, Hosseinipour MC. Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries. Vaccines. 2021 May 17;9(5):515.
  • Zhu XM, Yan W, Sun J, Liu L, Zhao YM, Zheng YB, Que JY, Sun SW, Gong YM, Zeng N. Patterns and influencing factors of COVID-19 vaccination willingness among college students in China. Vaccine. 2022 May 11;40(22):3046–54.
  • Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, Zhang H, Feng H, Guo J, Fang H Public perceptions and acceptance of COVID-19 booster vaccination in China: a cross-sectional study. Vaccines. 2021 Dec;9(12):1461. doi:10.3390/vaccines9121461.
  • CDC. Possible side effects. 2022 Jan 12. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html#: :text=So%20far%2C%20reactions%20reported%20after,effects%20were%20mild%20to%20moderate.